Researchers are exploring the use of intelligent delivery platforms, including microneedle patches and smart nanoparticles, for targeted protein degradation in cancer therapy. These platforms are being investigated for their potential to deliver PROTACs, a type of therapeutic agent. The development of these platforms and therapeutic paradigms may offer new approaches for anti-cancer treatment.